Rigel Pharmaceuticals Inc (RIGL) Company Report Feb. 03, 2023, 00:10 UTC Rigel Announces Publication of REZLIDHIA™(olutasidenib) Phase 2 Clinical Results in Blood Advances Full text
There are no comments here yet...